Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 25, 2011 - Issue 3
625
Views
5
CrossRef citations to date
0
Altmetric
Research Articles

Synthesis and structure–activity relationship studies of cytotoxic cinnamic alcohol derivatives

, , , , , & show all
Pages 203-221 | Received 18 Jan 2009, Accepted 19 Feb 2009, Published online: 05 Jul 2010
 

Abstract

Three series of di- and trisubstituted derivatives of cinnamic alcohol and its conjugated dienol analogues were designed and synthesised. The derivatives were screened for cytotoxicity against nine tumour cell lines: KB, A549, Hela, CNE, PC-3, BEL-7404, HL-60, BGC823 and P388D1. Most of the cinnamic alcohol derivatives showed cytotoxic activity. The compound 7-(4′,5′-dichlorobenzyloxy)-6,8-dihydroxycinnamic alcohol (55) exhibited significant cytotoxicity to seven human tumour cell lines on a micromolar range, especially with regard to the KB and P388D1 cell lines, showing IC50 values of 0.4 and 0.5 µM, respectively. The structure–activity relationships of the derivatives are discussed.

Acknowledgements

This work was in part financially supported by the Special Foundation 985 from Zhejiang University, the German Science Foundation (Bad Godesberg) and Zhejiang University K.P. Chao's Foundation. The authors are grateful to Prof. Handong Sun and Prof. Jun Zhou (KIB, CAS), as well as to Françoise Guéritte (ICSN, CNRS) for their interest in this research topic. We thank Dr Jiali Luo and Mr Xiaoren Wang at the R&D Centre of Zhejiang Hisun Group for measuring the mass data.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.